【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Markers used for diagnosis of solid tumors
PART 05: Cost analysis
PART 06: Pipeline portfolio
• Anticipated number of products with single and multiple indications by 2020
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by molecule type
• Small molecules
• Biologics
PART 09: Market segmentation by type of therapy
• Chemotherapy
• Hormone therapy
• Targeted therapy
• Immunotherapy
PART 10: Market segmentation by disease
• Global breast cancer drugs market
• Global NHL drugs market
• Global colorectal cancer drugs market
• Global NSCLC drugs market
• Global prostate cancer drugs market
• Global kidney cancer drugs market
• Global retinoblastoma drugs market
• Global cervical cancer market
• Global melanoma drugs market
• Global gastric cancer drugs market
• Global pancreatic cancer drugs market
• Global ovarian cancer drugs market
• Global liver cancer drugs market
• Global HL drugs market
• Global glioblastoma multiforme drugs market
PART 11: Geographical segmentation
• Solid tumors drugs market in Americas
• Solid tumors drugs market in EMEA
• Solid tumors drugs market in APAC
PART 12: Market drivers
• Patient assistance programs
• Exposure to risk factors
• Provision for rare diseases
• Promising pipeline
• Increase in prevalence of solid tumors
PART 13: Impact of drivers
PART 14: Market challenges
• Patent expiration of top-selling drugs
• Poor diagnosis and screening
• High cost of drugs
• Availability of chemotherapy and off-label drugs
• Stringent regulations
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Joint ventures and partnerships for R&D
• Increase in use of brachytherapy
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• F. Hoffmann-La Roche
• Novartis
• Celgene
• Johnson & Johnson
• Pfizer
• BMS
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Types of solid tumors
Exhibit 03: Markers used for types of solid tumors
Exhibit 04: Annual treatment cost per patient for solid tumor drugs 2014
Exhibit 05: Average cost of surgeries associated with solid tumors 2014 ($)
Exhibit 06: Average cost of chemotherapy 2014 ($)
Exhibit 07: Average cost of radiation therapy 2014 ($)
Exhibit 08: Phase III pipeline molecules for solid tumors
Exhibit 09: Phase II pipeline molecules for solid tumors
Exhibit 10: Phase I pipeline molecules for solid tumors
Exhibit 11: Pre-clinical pipeline molecules for solid tumors
Exhibit 12: Pipeline share of solid tumors drugs 2015
Exhibit 13: Near-launch immuno-oncology pipeline assets 2020
Exhibit 14: Global solid tumors market 2015-2020 ($ billions)
Exhibit 15: Factors influencing global solid tumors drugs market 2015
Exhibit 16: Five forces analysis
Exhibit 17: Segmentation of global solid tumors drugs market by type of molecules 2015
Exhibit 18: Market segmentation by disease
Exhibit 19: Global solid tumors drugs market: Segmentation by disease 2015
Exhibit 20: Global solid tumors drugs market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 21: Stages of breast cancer based on tumor size and extent of metastasis
Exhibit 22: Classification of breast cancer based on genetic makeup of tumor cells
Exhibit 23: Treatment regimen for breast cancer
Exhibit 24: Product offerings for breast cancer drugs market
Exhibit 25: Global breast cancer drugs market 2015-2020 ($ billions)
Exhibit 26: Product offerings for global NHL drugs market
Exhibit 27: Global NHL drugs market 2015-2020 ($ billions)
Exhibit 28: Product offerings for global colorectal cancer drugs market
Exhibit 29: Global colorectal cancer drugs market 2015-2020 ($ billions)
Exhibit 30: Products offerings for global NSCLC drugs market
Exhibit 31: Global NSCLC drugs market 2015-2020 ($ billions)
Exhibit 32: Product offerings for global prostate cancer drugs market
Exhibit 33: Global prostate cancer drugs market 2015-2020 ($ billions)
Exhibit 34: Product offerings for global kidney cancer drugs market
Exhibit 35: Global kidney cancer drugs market 2015-2020 ($ billions)
Exhibit 36: Product offerings for global retinoblastoma drugs market
Exhibit 37: Global retinoblastoma drugs market 2015-2020 ($ billions)
Exhibit 38: Product offerings for global cervical cancer market
Exhibit 39: Global cervical cancer market 2015-2020 ($ billions)
Exhibit 40: Product offerings for global melanoma drugs market
Exhibit 41: Global melanoma drugs market 2015-2020 ($ billions)
Exhibit 42: Products offerings for global gastric cancer drugs market
Exhibit 43: Global gastric cancer drugs market 2015-2020 ($ billions)
Exhibit 44: Products offerings for global pancreatic cancer drugs market
Exhibit 45: Global pancreatic cancer drugs market 2015-2020 ($ billions)
Exhibit 46: Products offerings for global ovarian cancer drugs market
Exhibit 47: Global ovarian cancer drugs market 2015-2020 ($ billions)
Exhibit 48: Product offerings for global liver cancer drugs market
Exhibit 49: Global liver cancer drugs market 2015-2020 ($ billions)
Exhibit 50: Products offerings for global HL drugs market
Exhibit 51: Global HL drugs market 2015-2020 ($ millions)
Exhibit 52: Products offerings for global glioblastoma multiforme drugs market
Exhibit 53: Global glioblastoma multiforme drugs market 2015-2020 ($ millions)
Exhibit 54: Global solid tumors drugs market by geography 2015
Exhibit 55: Global solid tumors drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 56: Global solid tumors drugs market revenue by geography 2015-2020
Exhibit 57: Solid tumors drugs market in Americas 2015-2020 ($ billions)
Exhibit 58: Solid tumors drugs market in EMEA 2015-2020 ($ billions)
Exhibit 59: Solid tumors drugs market in APAC 2015-2020 ($ billions)
Exhibit 60: Global solid tumors drugs market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 61: Global incidence of solid tumor types 2015
Exhibit 62: Global mortality of solid tumor types 2015
Exhibit 63: Impact of drivers
Exhibit 64: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 65: Average cost comparison of Herceptin 2014
Exhibit 66: Impact of drivers and challenges
Exhibit 67: Expected combination regimen launches in oncology
Exhibit 68: YoY Sales comparison of top drugs 2013-2015 ($ billions)
Exhibit 69: Ranking of major vendors for global solid tumors drugs market
Exhibit 70: Market share analysis of global solid tumors drugs market 2015
Exhibit 71: F. Hoffmann-La Roche: YoY growth and revenue generated from total product sales of MabThera/Rituxan (oncology indications) 2013-2015 ($ billions)
Exhibit 72: MabThera/Rituxan geographic segmentation by revenue 2015
Exhibit 73: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 74: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 75: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2013-2015 ($ billions)
Exhibit 76: F. Hoffmann-La Roche: Geographical segmentation of Herceptin 2015
Exhibit 77: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2013-2015 ($ billions)
Exhibit 78: F. Hoffmann-La Roche: Geographical segmentation of Perjeta 2015
Exhibit 79: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2015 ($ millions)
Exhibit 80: F. Hoffmann-La Roche: Geographical segmentation of Kadycla 2015
Exhibit 81: F. Hoffmann-La Roche: Revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 82: F. Hoffmann-La Roche: Geographical segmentation of Tarceva 2015
Exhibit 83: F. Hoffmann-La Roche: Key takeaways
Exhibit 84: Novartis: YoY revenue and growth rate of Gleevec 2013-2015 ($ billions)
Exhibit 85: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 86: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 87: Novartis: Key takeaways
Exhibit 88: Celgene: YoY revenue and growth rate of Revlimid 2013-2015 ($ billions)
Exhibit 89: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
Exhibit 90: Celgene: YoY revenue and growth rate of Istodax 2013-2015 ($ millions)
Exhibit 91: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 92: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 93: Celgene: Key takeaways
Exhibit 94: Johnson & Johnson: YoY revenue comparison of Zytiga 2013-2015 ($ billions)
Exhibit 95: Johnson & Johnson: YoY revenue comparison of Velcade 2013-2015 ($ billions)
Exhibit 96: Johnson & Johnson: YoY revenue comparison of Imbruvica 2014-2015 ($ millions)
Exhibit 97: Key takeaways
Exhibit 98: Pfizer: YoY revenue and growth rate of Sutent 2013-2015 ($ billions)
Exhibit 99: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 100: Pfizer: YoY revenue and growth rate of Inlyta 2013-2015 ($ millions)
Exhibit 101: Key takeaways
Exhibit 102: BMS: YoY revenue and growth rate of Erbitux 2013-2015 ($ millions)
Exhibit 103: BMS: YoY revenue and growth rate of Sprycel 2013-2015 ($ billions)
Exhibit 104: Key takeaways
【レポート販売概要】
■ タイトル：固形腫瘍治療薬の世界市場2016-2020■ 英文：Global Solid Tumors Drugs Market 2016-2020
■ 発行日：2016年6月24日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9801
■ 調査対象地域：グローバル
- 建設・土工分野におけるディーゼルエンジンの世界市場2017-2021ABSTRACTAbout Diesel Engines for Construction and Earthmoving Sector Diesel engines are internal combustion engines that use diesel as a fuel. Another characteristic that distinguishes them is the use of compression ignition rather than spark ignition in gasoline-powered engines. Diesel-powered engines produce high torque, and thus, are suitable for construction and earthmoving equipment. Technavi …
- 蠕虫症(Helminthiasis)：世界の治験レビュー（2015年上半期版）Helminthiasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, H1, 2015" provides data on the Helminthiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Helminthiasis. It includes an overview of the trial numbers and their recruitment status as per the …
- 海洋VSAT（超小型地球局）の世界市場2015-2019Covering: Growth prospects and market forecast of the global maritime VSAT services market and a segmentation analysis by technology (HTS, L-band, KU-band, and C-band), and by number of terminals (Ka-band, c-band, and Ku-band). Market shares for APAC, Americas, and the EMEA are included in this report. The leading vendors analyzed in this report include Harris Caprock, Hughes, Inmarsat, KVH, RigNe …
- ハニカムボード包装の世界市場2016-2020About Honeycomb Paperboard Packaging Honeycomb paperboard packaging is a kind of protective packaging used before shipping of products. It is good as shock absorber, bracing, cradling, void fillers, cushion, and can be used for expandable pallets. It is an environment-friendly packaging solution, which is 100% recyclable. The unique design of honeycomb packaging products gives them advantage over …
- 通信キャリアWiFiの世界市場As smartphones and tablets have become increasingly ubiquitous, the increasing mobility advantage offered by these devices means that consumers have come to expect a high standard of network connectivity at all times. Consequently, global data traffic increased from 820 petabytes/month in 2012 to 1.5 exabytes/month in 2013 and 2.8 exabytes/month in 2014. In 2015, visiongain expects the average glo …
- Epzicom (HIV)：市場予測と分析（～2022）Epzicom (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Epzicom (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a dea …
- 垂直農法の世界市場予測（～2022）：栽培方法別（水耕栽培、空中栽培、アクアポニックス）、構造別、提供方法別、作物種類別、地域別According to the new market research report, the vertical farming market is expected to be valued at USD 5.80 Billion by 2022, growing at a CAGR of 24.8% between 2016 and 2022. The growth of the vertical farming market could be attributed to the growing urbanization, rising demand for high quality food with no use of pesticides and herbicides, and independent farming technique with low impact of c …
- 電気ショベルの世界市場2015-2019About Global Electric Shovel Market An electric shovel is used in activities related to mining, digging, and loading of earth or fragmented rocks. It is a modified steam shovel and operates in a similar fashion. Though the main purpose of shovels is to excavate and decrease burden in open-pit mining operations, it may also be used for loading extracted minerals such as coal. Technavio's analysts f …
- ポリプロピレン繊維の世界市場2019-2023About this market The growing textile industry is one of the key factors expected to propel the market growth during the forecast period. Polypropylene fiber exhibits several features suitable for manufacturing clothing and surgical textile products including face masks, gauzes, and adhesive tapes. Furthermore, many textile companies are setting up manufacturing units in the emerging economies for …
- 世界の自動車用スピーカー市場2015The Global Automotive Speaker Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Speaker industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Speaker market analysis is provided for the international markets including development trends, competiti …
- 自動車用温度センサーの世界市場2017-2021About Automotive Temperature SensorsTemperature sensors are used to measure the temperature by converting thermal energy into electrical energy, which is used to interpret the temperature. The rising requirement for precise measurements and data drove the demand for the automotive temperature sensors in a wider segment of passenger cars, especially mid-segment cars. The report covers only automoti …
- ネットワーク・フォレンジックス（鑑識）の世界市場予測（～2021）The network forensics market size is expected to grow from USD 1.25 Billion in 2016 to USD 2.69 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period. The major growth drivers of the market include increased need to secure networks from advanced attacks, such as ransomware, Distributed Denial of Service (DDoS), and Advanced Persistent Threats (APTs); increase …
- Permian Basin Royalty Trust：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- Miller Energy, Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年）Miller Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Miller Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 固定式･可動式Cアームの世界市場分析：製品別（固定･持ち運びサイズ：フルサイズ/ミニCアーム）、用途別（整形外科、脳神経外科、心臓外科、血管外科、疼痛管理）、セグメント予測、2014-2025The global fixed & mobile C-arms market is expected to reach USD 2.3 billion by 2025, according to a new report by Grand View Research, Inc. Growing prevalence of chronic diseases that require early diagnosis and on-time treatment for prevention of complications and rising number of road accidents leading to orthopedic injuries are propelling the demand for fixed and mobile C-arm devices. In addit …
